SlideShare a Scribd company logo
1 of 28
PERTUSSIS
K.R POKHREL
MBBS,KUSMS
Pertussis
-whooping cough ,100 days cough
-pertussis=intense cough(most individuals don’t
whoop)
Causative agent:
-Bordetella Pertussis
-Bordetella Parapertussis
-Bordetella Holmessi,Bordetella Bronchiseptica
• Small,ovoid,fastidious,Gram negative
coccobacilli,0.5 microns length
• Nonmotile,non sporing,capsulated,aerobic
• Colonize only ciliated epithelium
Epidemiology
• Worldwide
• 1922-1948 leading cause of death
• 2008(WHO)-16 million cases;195000
childhood deaths esp in developing countries
• U.S-leading cause of death <14 yrs(10000
deaths/yr)before vaccines were available
• After the advent of pertussis vaccine->99%
decline on cases and shift of disease burden to
adolescents and adults
• Extremely contagious-attack rates 80-100%
• Source of infection=cases
• Chronic carriers not known
• Immunity never complete(waning protection following
vaccination)
• Adolescents and adults are major reservoir but
unrecognized
• Age:any age, most prevalent(<5 yrs )most severe(<6
months)
• Incubation Period:3-12 days
• Infectivity:first 4 weeks
• Transmission by droplets and direct contact
• Nepal 2015 A.D
-4416 cases of pertussis reported
-DTP3 coverage of 91%
2016 A.D
-4890 cases of pertussis reported
-DTP3 coverage 87%
Pathogenesis(toxin mediated)
Aerosol acquisition
colonize ciliated epithelium of respiratory tract(via
adhesins)
Expression of toxins (Pertussis toxin,Tracheal
cytotoxin,Adenylate cyclase,Dermonecrotic factor)
Paralyze cilia,Increase in cAMP(mucus
hypersecretion,inflammation) and inhibit clearance
of organisms-interferes with clearing of secretions
modifies host defences(lymphocytosis+impaired
chemotaxis)
local epithelial damage causing respiratory
symptoms and invasion into tissues(macrophages)
Immune response by body
Neutralization the toxins
Clinical Manifestations
• 3 Stages
1)Catarrhal Stage
• 1-2 weeks
• Congestion,rhinorrhea,
• low grade fever
• sneezing,lacrimation,conjunctival suffusion
• Most contagious at this stage
2)Paroxysmal Stage
• 2-6 weeks
• Coughing marks its onset
• Initially dry,irritant,intermittent hack
• Progresses to inexorable paroxysm(hallmarks
of pertussis)
• Machine gun burst of uninterrupted cough on
a single exhalation
• Chin and chest held forward
• Tongue maximally protruded
• Eyes bulging ,watering
• Face red then blue
• Loud whoop(high pitched inspiration) at the end
of paroxysm
• Posttussive emesis and exhaustion
• Number and severity progresses over days to
weeks then plateau for days to week(peak >1
episodes/hr)
• 3)Convalescent Stage(>/=2 weeks)
• Number,severity and duration of episodes
diminishes
• Upto months
• Risk of developing secondary infections
common in this stage
Infants <3 months
• No classical stages
• Well appearing infant suddenly
chokes,gasps,gags,flail extremities,reddened
face
• Cough not prominent,whoop infrequent
• Apnea and cyanosis
• Young infants-paroxysmal and convalescent
stage longer
• Immunized children-foreshortened stages
• Adolescents and adults-no distinct stage,milder
-sudden feeling of strangulation
-suffocation,headache,diminished
awareness
-gasping without whoop
-post tussive emesis and intermittent
paroxysms separated by hours of well being
-non specific cough>21 days
• Physical examination not informative
-signs of LRT involvement,conjunctival
hemorrhages and petechiae
Diagnosis
• Clinical Diagnosis-Paroxysmal stage
• Suspect if predominant cough with absent
-fever,malaise,myalgia,rash,sorethroat,
hoarseness,tachypnea,wheeze,crepitations
• Cough>/=14 days+symptoms of paroxysm,whoop
or post tussive emesis
• Older children=escalating intermittent cough for
7-10 days
• <3 months=gagging,gasping,apnea,cyanosis
Investigations
1.Blood Count
-leukocytosis(15000-100000/mm3)with absolute
lymphocytosis(>/=50%)
2.Culture
-Nasopharyngeal aspirate(dacron/calcium alginate swabs)
-Bordet Gengou Potato Infusion media,Regan Lowe
charcoal media
3.Fluorescent Antibody staining,Serology
4.PCR
5.Chest Xray
-perihilar infiltrates,atelectasis
• Gram negative coccobacilli
• B.G media-small,white domed pearls
• R.L media-mercury droplets
Differential Diagnosis
• Viral infections(Adenovirus,Respiratory
Syncytial Virus)-
fever,sorethroat,conjunctivitis,LRT signs
• Chlamydial Infections-
conjunctivitis,tachypnea,rales
• Mycoplasma infection-
fever,headache,rales,continous cough
• Pulmonary tuberculosis-fever,weight
loss,night sweats
Complications
1.Respiratory
-Apnea,Respiratory failure
-Bronchopneumonia
-Atelectasis
-Bronchiectasis
-Pneumothorax,Emphysema
-Pulmonary Hypertension
-Reactivation of quiescient TB
Others -Otitis media
2.Sequelae of forceful cough
-Epistaxis,Sub conjunctival and scleral
hemorrhage
-petechia on upper body
-Intracranial bleeding
-Retinal hemorrhage
-Umbilical and inguinal hernia
-Rectal prolpase
-Dehydration,malnutrition
3.CNS
-convulsions,encephalopathy
Treatment
Specific(antibiotics)
• Effective in early catarrhal phase
• Late phases-reduce transmission but doesn’t alter the
course of disease(>3 wks and not pregnant=no role)
• Primary agents
-Azithromycin-DOC(10mg/kg/day once daily for 5 days)
-Erythromycin(40-50 mg/kg/day in 4 divided doses for 14
days)
-substantial risk for infantile hypertrophic pyloric stenosis
with erythromycin
• Secondary agents
-Clarithromycin 15mg/kg/day in 2 divided doses for
7 days
-Cotrimoxazole(TMP 8mg/kg/day + SMZ 40mg/kg
day)in 2divided doses for 14 days
• CI in <2 months
No role for adjunct therapies(B2 agonists,
corticosteriods)
General Measures
• Young infants should be hospitalised
• Adequate hydration and nutrition
• Oxygen,Mechanical ventilation
• Quiet environment
Paroxysms-not life threatening
-<45 secs,red but not blue color change
-tachycardia,bradycardia or oxygen desaturation with
spontaneous resolution after paroxysm
-whooping,self expectoration of mucus plug
-post tussive exhaustion but not unresponsiveness
Criteria for Discharge
• Disease severity unchanged/diminished over
48 hr period
• No intervention required during paroxysm
• Adequate nutrition
• No complications
• Parents prepared for care at home
Care of household and close contacts
• Macrolides given(irrespective of
age,immunization status,symptoms)-dose same
as for treatment
• Vaccination
-close contacts <7 yrs , < 4 doses then complete the
series
-< 7 yrs,3rd dose >6months before exposure
-<7 yrs,4th dose>/=3 yrs before exposure
->9 yrs give if not previously received
• If contacts develop cough-evaluate for pertussis
booster
Prevention
• Vaccination
-2 types:DPT(whole cell) and DTaP(acellular)
-DPT vaccine in Nepal(Since 2009 A.D,component of
pentavalent)
-0.5ml IM in anterolateral thigh at 6,10 and 14
weeks included in National EPI schedule of Nepal
-recommendation:5 doses:4 in 1st 2yrs of life,6
months gap between 3rd and 4th
5th dose-4-6 yrs;not required if 4th dose acquired at
or after 4th birthday
-only acellular vaccines for older children and adults
• Adverse effects-fever,pain,redness,swelling
• Rarely abscess formation,inconsolable
screaming,seizures,hypotonic
hyporesponsiveness,anaphylaxis
• Contraindications
-Progressive neurological disease
-anaphylaxis after previous dose
-encephalopathy within 7 days of previous dose
• Tdap-in pregnant??
-passive immunity to child until vaccinated
• Continues to be endemic despite high vaccination coverage
References
• Nelson Textbook of Pediatrics 20th Edition
• Park’s Textbook of Preventive and Social Medicine
22nd Edition
• http://www.searo.who.int/immunization/data/ne
pal
• UPTODATE
Thank You!!!

More Related Content

What's hot (20)

Pertussis Overview
Pertussis OverviewPertussis Overview
Pertussis Overview
 
Bronchiectasis
Bronchiectasis Bronchiectasis
Bronchiectasis
 
Enteric fever in children
Enteric fever in childrenEnteric fever in children
Enteric fever in children
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Chickenpox
ChickenpoxChickenpox
Chickenpox
 
Diptheria
DiptheriaDiptheria
Diptheria
 
Scarlet fever ( infectious diseases )
Scarlet fever ( infectious diseases )Scarlet fever ( infectious diseases )
Scarlet fever ( infectious diseases )
 
Pertussis
PertussisPertussis
Pertussis
 
Bronchiolitis in children
Bronchiolitis in childrenBronchiolitis in children
Bronchiolitis in children
 
Tonsillitis
TonsillitisTonsillitis
Tonsillitis
 
Pertusis (Whooping cough) by Sunil Kumar Daha
Pertusis (Whooping cough) by Sunil Kumar DahaPertusis (Whooping cough) by Sunil Kumar Daha
Pertusis (Whooping cough) by Sunil Kumar Daha
 
Relapsing fever notes
Relapsing fever notesRelapsing fever notes
Relapsing fever notes
 
Epiglottitis
EpiglottitisEpiglottitis
Epiglottitis
 
Pertussis/Whooping cough
Pertussis/Whooping coughPertussis/Whooping cough
Pertussis/Whooping cough
 
Pertussis
PertussisPertussis
Pertussis
 
(E pi) intestinal infections
(E pi) intestinal infections(E pi) intestinal infections
(E pi) intestinal infections
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
pneumonia
pneumoniapneumonia
pneumonia
 
Pseudotuberculosis
PseudotuberculosisPseudotuberculosis
Pseudotuberculosis
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 

Similar to Everything You Need to Know About Pertussis (Whooping Cough

Similar to Everything You Need to Know About Pertussis (Whooping Cough (20)

ARI Year 2019.pptx
ARI Year 2019.pptxARI Year 2019.pptx
ARI Year 2019.pptx
 
Acute respiratory infections
Acute respiratory infections Acute respiratory infections
Acute respiratory infections
 
Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)
 
Acute Respiratory infecions
Acute Respiratory infecionsAcute Respiratory infecions
Acute Respiratory infecions
 
Acute respiratory infections
Acute respiratory infectionsAcute respiratory infections
Acute respiratory infections
 
acuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdfacuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdf
 
20180319 poliomyelitis
20180319 poliomyelitis20180319 poliomyelitis
20180319 poliomyelitis
 
Pertusis
PertusisPertusis
Pertusis
 
20180211 pertussis
20180211 pertussis20180211 pertussis
20180211 pertussis
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
Pertussis
PertussisPertussis
Pertussis
 
Pertussis
PertussisPertussis
Pertussis
 
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
 
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
 
Pertusses associated cough
Pertusses associated coughPertusses associated cough
Pertusses associated cough
 
Measles infection and mmr
Measles  infection  and mmrMeasles  infection  and mmr
Measles infection and mmr
 
Rubella.pptx
Rubella.pptxRubella.pptx
Rubella.pptx
 
Case presentation tb meningitis
Case presentation tb meningitisCase presentation tb meningitis
Case presentation tb meningitis
 
Bronchiolitis overview
Bronchiolitis   overviewBronchiolitis   overview
Bronchiolitis overview
 
Pediatric tuberculosis
Pediatric tuberculosisPediatric tuberculosis
Pediatric tuberculosis
 

Recently uploaded

Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxabhijeetpadhi001
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 

Recently uploaded (20)

Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 

Everything You Need to Know About Pertussis (Whooping Cough

  • 2. Pertussis -whooping cough ,100 days cough -pertussis=intense cough(most individuals don’t whoop) Causative agent: -Bordetella Pertussis -Bordetella Parapertussis -Bordetella Holmessi,Bordetella Bronchiseptica
  • 3. • Small,ovoid,fastidious,Gram negative coccobacilli,0.5 microns length • Nonmotile,non sporing,capsulated,aerobic • Colonize only ciliated epithelium
  • 4. Epidemiology • Worldwide • 1922-1948 leading cause of death • 2008(WHO)-16 million cases;195000 childhood deaths esp in developing countries • U.S-leading cause of death <14 yrs(10000 deaths/yr)before vaccines were available • After the advent of pertussis vaccine->99% decline on cases and shift of disease burden to adolescents and adults
  • 5. • Extremely contagious-attack rates 80-100% • Source of infection=cases • Chronic carriers not known • Immunity never complete(waning protection following vaccination) • Adolescents and adults are major reservoir but unrecognized • Age:any age, most prevalent(<5 yrs )most severe(<6 months) • Incubation Period:3-12 days • Infectivity:first 4 weeks • Transmission by droplets and direct contact
  • 6. • Nepal 2015 A.D -4416 cases of pertussis reported -DTP3 coverage of 91% 2016 A.D -4890 cases of pertussis reported -DTP3 coverage 87%
  • 7. Pathogenesis(toxin mediated) Aerosol acquisition colonize ciliated epithelium of respiratory tract(via adhesins) Expression of toxins (Pertussis toxin,Tracheal cytotoxin,Adenylate cyclase,Dermonecrotic factor) Paralyze cilia,Increase in cAMP(mucus hypersecretion,inflammation) and inhibit clearance of organisms-interferes with clearing of secretions
  • 8. modifies host defences(lymphocytosis+impaired chemotaxis) local epithelial damage causing respiratory symptoms and invasion into tissues(macrophages) Immune response by body Neutralization the toxins
  • 9. Clinical Manifestations • 3 Stages 1)Catarrhal Stage • 1-2 weeks • Congestion,rhinorrhea, • low grade fever • sneezing,lacrimation,conjunctival suffusion • Most contagious at this stage
  • 10. 2)Paroxysmal Stage • 2-6 weeks • Coughing marks its onset • Initially dry,irritant,intermittent hack • Progresses to inexorable paroxysm(hallmarks of pertussis) • Machine gun burst of uninterrupted cough on a single exhalation
  • 11. • Chin and chest held forward • Tongue maximally protruded • Eyes bulging ,watering • Face red then blue • Loud whoop(high pitched inspiration) at the end of paroxysm • Posttussive emesis and exhaustion • Number and severity progresses over days to weeks then plateau for days to week(peak >1 episodes/hr)
  • 12. • 3)Convalescent Stage(>/=2 weeks) • Number,severity and duration of episodes diminishes • Upto months • Risk of developing secondary infections common in this stage
  • 13. Infants <3 months • No classical stages • Well appearing infant suddenly chokes,gasps,gags,flail extremities,reddened face • Cough not prominent,whoop infrequent • Apnea and cyanosis • Young infants-paroxysmal and convalescent stage longer • Immunized children-foreshortened stages
  • 14. • Adolescents and adults-no distinct stage,milder -sudden feeling of strangulation -suffocation,headache,diminished awareness -gasping without whoop -post tussive emesis and intermittent paroxysms separated by hours of well being -non specific cough>21 days • Physical examination not informative -signs of LRT involvement,conjunctival hemorrhages and petechiae
  • 15. Diagnosis • Clinical Diagnosis-Paroxysmal stage • Suspect if predominant cough with absent -fever,malaise,myalgia,rash,sorethroat, hoarseness,tachypnea,wheeze,crepitations • Cough>/=14 days+symptoms of paroxysm,whoop or post tussive emesis • Older children=escalating intermittent cough for 7-10 days • <3 months=gagging,gasping,apnea,cyanosis
  • 16. Investigations 1.Blood Count -leukocytosis(15000-100000/mm3)with absolute lymphocytosis(>/=50%) 2.Culture -Nasopharyngeal aspirate(dacron/calcium alginate swabs) -Bordet Gengou Potato Infusion media,Regan Lowe charcoal media 3.Fluorescent Antibody staining,Serology 4.PCR 5.Chest Xray -perihilar infiltrates,atelectasis
  • 17. • Gram negative coccobacilli • B.G media-small,white domed pearls • R.L media-mercury droplets
  • 18. Differential Diagnosis • Viral infections(Adenovirus,Respiratory Syncytial Virus)- fever,sorethroat,conjunctivitis,LRT signs • Chlamydial Infections- conjunctivitis,tachypnea,rales • Mycoplasma infection- fever,headache,rales,continous cough • Pulmonary tuberculosis-fever,weight loss,night sweats
  • 20. 2.Sequelae of forceful cough -Epistaxis,Sub conjunctival and scleral hemorrhage -petechia on upper body -Intracranial bleeding -Retinal hemorrhage -Umbilical and inguinal hernia -Rectal prolpase -Dehydration,malnutrition 3.CNS -convulsions,encephalopathy
  • 21. Treatment Specific(antibiotics) • Effective in early catarrhal phase • Late phases-reduce transmission but doesn’t alter the course of disease(>3 wks and not pregnant=no role) • Primary agents -Azithromycin-DOC(10mg/kg/day once daily for 5 days) -Erythromycin(40-50 mg/kg/day in 4 divided doses for 14 days) -substantial risk for infantile hypertrophic pyloric stenosis with erythromycin
  • 22. • Secondary agents -Clarithromycin 15mg/kg/day in 2 divided doses for 7 days -Cotrimoxazole(TMP 8mg/kg/day + SMZ 40mg/kg day)in 2divided doses for 14 days • CI in <2 months No role for adjunct therapies(B2 agonists, corticosteriods)
  • 23. General Measures • Young infants should be hospitalised • Adequate hydration and nutrition • Oxygen,Mechanical ventilation • Quiet environment Paroxysms-not life threatening -<45 secs,red but not blue color change -tachycardia,bradycardia or oxygen desaturation with spontaneous resolution after paroxysm -whooping,self expectoration of mucus plug -post tussive exhaustion but not unresponsiveness
  • 24. Criteria for Discharge • Disease severity unchanged/diminished over 48 hr period • No intervention required during paroxysm • Adequate nutrition • No complications • Parents prepared for care at home
  • 25. Care of household and close contacts • Macrolides given(irrespective of age,immunization status,symptoms)-dose same as for treatment • Vaccination -close contacts <7 yrs , < 4 doses then complete the series -< 7 yrs,3rd dose >6months before exposure -<7 yrs,4th dose>/=3 yrs before exposure ->9 yrs give if not previously received • If contacts develop cough-evaluate for pertussis booster
  • 26. Prevention • Vaccination -2 types:DPT(whole cell) and DTaP(acellular) -DPT vaccine in Nepal(Since 2009 A.D,component of pentavalent) -0.5ml IM in anterolateral thigh at 6,10 and 14 weeks included in National EPI schedule of Nepal -recommendation:5 doses:4 in 1st 2yrs of life,6 months gap between 3rd and 4th 5th dose-4-6 yrs;not required if 4th dose acquired at or after 4th birthday -only acellular vaccines for older children and adults
  • 27. • Adverse effects-fever,pain,redness,swelling • Rarely abscess formation,inconsolable screaming,seizures,hypotonic hyporesponsiveness,anaphylaxis • Contraindications -Progressive neurological disease -anaphylaxis after previous dose -encephalopathy within 7 days of previous dose • Tdap-in pregnant?? -passive immunity to child until vaccinated • Continues to be endemic despite high vaccination coverage
  • 28. References • Nelson Textbook of Pediatrics 20th Edition • Park’s Textbook of Preventive and Social Medicine 22nd Edition • http://www.searo.who.int/immunization/data/ne pal • UPTODATE Thank You!!!

Editor's Notes

  1. B pertussis-epidemics and sporadic cases B parapertussis-<5%
  2. Adhesins and Toxins
  3. Protection wanes of in 6-12 yrs following vaccination
  4. Culture 30-50% positive,may take upto 2 weeks’;less likely to be positive if >2 weeks after cough onset or from vaccinated/treated individuals PCR-high sensitivity.many false positives,variable specificity;upto 3 weeks of cough onset accurate results;>4 weeks DNA levels fall so PCR unreliable Serology-effective in later stage when cultures and PCR likely to be negative;highest yield 2-8 weeks following cough onset
  5. Charcoal containing media bordet gengou Slow growing 48-72 hrs
  6. Risk for kernicterus with SMZ so CI in <2 months
  7. DPT-whole cell vaccine,used in developing countries,effective for long duration =10 yrs DTaP-acellular,developed countries,less side effects,effective for shorter duration,less reactogenicity,more expensive Efficacy=85% Protection for 6-12 years following 3 doses and 1 booster which is similar/shorter to that following natural infection
  8. Tdap-tetanus,reduced diphtheria and acellular pertussis,used in developed countries,pregnant women optimal time 26-37 weeks,confers passive immunity to child until he/she receives vaccines